Truist Financial Corp Reduces Stock Holdings in Nutex Health Inc. $NUTX

Truist Financial Corp reduced its stake in shares of Nutex Health Inc. (NASDAQ:NUTXFree Report) by 22.7% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 24,419 shares of the company’s stock after selling 7,151 shares during the period. Truist Financial Corp’s holdings in Nutex Health were worth $3,040,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the stock. One Plus One Wealth Management LLC raised its holdings in shares of Nutex Health by 3.3% during the 2nd quarter. One Plus One Wealth Management LLC now owns 38,791 shares of the company’s stock valued at $4,829,000 after buying an additional 1,250 shares during the period. Bank of America Corp DE raised its holdings in shares of Nutex Health by 6,590.3% during the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock valued at $66,000 after buying an additional 2,043 shares during the period. OMERS ADMINISTRATION Corp raised its holdings in shares of Nutex Health by 28.8% during the 1st quarter. OMERS ADMINISTRATION Corp now owns 9,400 shares of the company’s stock valued at $442,000 after buying an additional 2,100 shares during the period. Goldman Sachs Group Inc. grew its stake in Nutex Health by 17.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company’s stock valued at $852,000 after purchasing an additional 2,748 shares in the last quarter. Finally, Baader Bank Aktiengesellschaft grew its stake in Nutex Health by 64.6% during the 1st quarter. Baader Bank Aktiengesellschaft now owns 10,700 shares of the company’s stock valued at $503,000 after purchasing an additional 4,200 shares in the last quarter. 5.32% of the stock is currently owned by hedge funds and other institutional investors.

Nutex Health Stock Up 0.9%

Shares of Nutex Health stock opened at $103.68 on Friday. The business’s fifty day moving average price is $94.26 and its two-hundred day moving average price is $111.14. The company has a debt-to-equity ratio of 1.02, a current ratio of 2.27 and a quick ratio of 2.26. The company has a market capitalization of $576.46 million, a P/E ratio of 8.72 and a beta of -0.20. Nutex Health Inc. has a 1-year low of $17.75 and a 1-year high of $184.27.

Analyst Upgrades and Downgrades

NUTX has been the subject of a number of recent analyst reports. Weiss Ratings restated a “hold (c-)” rating on shares of Nutex Health in a research note on Wednesday. Maxim Group set a $205.00 price objective on Nutex Health and gave the company a “buy” rating in a research note on Tuesday, August 26th. Finally, Wall Street Zen upgraded Nutex Health from a “hold” rating to a “strong-buy” rating in a research note on Friday, September 26th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $252.50.

Read Our Latest Stock Analysis on Nutex Health

Nutex Health Profile

(Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Read More

Want to see what other hedge funds are holding NUTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutex Health Inc. (NASDAQ:NUTXFree Report).

Institutional Ownership by Quarter for Nutex Health (NASDAQ:NUTX)

Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.